We combine visionary thinking and compassionate care with the science of treating cancer. An NCI-designated Comprehensive Cancer Center, part of
@NYULangone
Congratulations to
@DrBenNeel
, director of our cancer center, who was just elected to the
@theNASciences
in recognition of distinguished and continuing achievements in original research. High honor for a scientist!
Read more:
Congrats to Associate Professor of Biochemistry and Molecular Pharmacology, Dr. Karim Jean- Armache
@KJArmache
who is a recipient of the 2022 emerging leaders award by the
@TheMarkFdn
for his work in addressing unmet needs in cancer research.
Congrats to radiation oncologist Dr. Michael Pacold
@MichaelPacold
who is a recipient of the
@DamonRunyon
innovative award for his work in accelerating cancer research.
Learn more:
Congratulations to Gynecologic Oncologist Dr. Bhavana Pothuri
@BPothuri
on her election to The Society of Gynecologic Oncology board of directors.
@SGO_org
We're proud to share that our Dr. Eva Hernando-Monge is one of several recipients of the Translational Research Award through
@thevfoundation
’s "Grant of Her Own" program for her work in melanoma brain metastasis!
For more about the award:
Congrats to radiation oncologist Dr. Alec Kimmelman for being inducted to the Association of American Physicians (AAP). This is an honor extended to select doctors in biomedical research.
@NYULH_RadOnc
@nyulangone
🔗
Congrats to
@theLundLab
, on the 2022
@AACR
@bmsnews
Female Investigator Grant: Targeting lymphatic transport to boost immune memory & reduce recurrence.
@AACR
believes this project will have great impact, & recognizes her as a future leader in the field.
Elevated prostate-specific antigen (PSA) scores can help detect early-stage
#prostatecancer
. This metric helped
@FoxNews
correspondent
@CGasparino
beat his cancer early.
Charlie thanks our care team in this
@FoxNewsOpinion
story ⤵️
Her breast cancer misdiagnosed at age 29,
@AmericanCancer
's LaToya Williams came to
@nyulangone
's Perlmutter Cancer Center to rebuild trust & is now 15 yrs. cancer free. “The care I get at NYU spoiled me to never accept less. I feel seen and heard.”
@CancerNYNJ
@FinanceVSCancer
Our cancer researcher Dr. Amanda Lund (
@theLundLab
) seeks to understand mechanisms of cancer metastasis. Learn more about Dr. Lund's research and how it benefits people with cancer.
@TheMarkFdn
@CancerResearch
@nyulangone
🔗
Congratulations to our fearless director
@DrBenNeel
, an Academy of Science Fellow of the Royal Society of Canada!
@RSCTheAcademies
The 2023 fellows will be inducted and celebrated at the
#COEE2023
#RSC
annual meeting on November 17!
Learn more:
We’re pleased to welcome former
@NYUGSOM_HemeOnc
fellow &
@ASCO
award recipient, Dr. Minas P. Economides (
@minaseconomides
), to Perlmutter Cancer Center's Genitourinary Oncology—Manhattan team!
Learn about his expertise & research:
Congratulations to Jun Wang, PhD (
@jwang133
) and Iannis Aifantis, PhD (
@iannisaifantis1
), recipients of the
@TheMarkFdn
’s ASPIRE award for their trailblazing exploration of antigen presentation inhibitors in cancer immunotherapeutics.
Learn more:
Congratulations to our urologic oncology fellow Dr. Minas Economides (
@minaseconomides
), an
#ASCO23
Young Investigator Award recipient, for his work to advance the treatment of bladder cancer!
@ConquerCancerFd
@NYUGSOM_HemeOnc
Check out his team's work:
We are thrilled to announce the seven innovative early-career cancer researchers in NY and CT who are the Pershing Square Sohn Cancer Research Alliance’s 2022 Prize winners! Stay tuned for a little more about each of them throughout the day.
#PSSCRA22
Congratulations to our Dr. Joseph Ravenell, recipient of the
@AmericanCancer
Eugene O'Kelly Award at this year's 15th annual Financial Services Cares Gala at Cipriani 25 Broadway.
@pophealthNYC
@nyugrossman
Gene expression in tumor-adjacent tissue holds significant prognostic information in lung adenocarcinoma, research from
@NYUGSOM_PMED
finds.
Learn about the findings from investigators Dr. Igor Dolgalev (
@bioigor
) and Dr. Aristotelis Tsirigos (
@artsinyc
):
Congratulations to
@EmelineAvikiMD
, of Perlmutter Cancer Center at
@NYULangoneLI
, who will serve on the 2024-2025 board of directors for The Society of Gynecologic Oncology (
@SGO_Org
)!
#gyncsm
Learn about the SGO’s vision:
A study led by
@DrBenNeel
& Dr. Shohei Koide shows that an antibody helps kill cancer cells resistant to the KRAS inhibitor sotorasib.
The study suggests a new way to use immunotherapy to treat tumors with the KRAS-G12C mutation. ⤵️
Congratulations to our Dr. Abraham Chachoua, recognized by
@nyulangone
Dean and CEO Dr. Robert I. Grossman and the family of Robert Antonio Magliocco, Jr., with a named professorship at
@nyugrossman
's Dean's Honors Day!
Learn about his accomplishments:
Congratulations to six Perlmutter Cancer Center/
@NYUGrossman
scientists who have been named "Top Cited Researchers" by
@Clarivate
for publishing influential papers that rank in the top 1% of citations in their field in the past decade!
Learn more:
Studies led by researchers at
@nyulangone
reveal how melanoma metastasizes in the brain & how epigenetic regulation may aid its spread. Pathologist Dr. Eva Hernando-Monge comments on the two studies published in
@CD_AACR
.
@ScienceMagazine
Read more: ⤵️
This June, middle school students from
@SunsetParkPrep
joined our cancer biologists from
@nyulangone
for a mobile
@BioBus
visit to investigate the world through a different lens and experience the joy of scientific discovery! 🔬
Tonight’s
@CBS
Evening News will broadcast a breast cancer disparities segment shot at Perlmutter Cancer Center and features breast cancer surgeon
@Kathie_JosephMD
, patient LaToya Williams & others. It will highlight what needs to be done to reduce barriers for women of color.
@MaurerFdn
is celebrating trailblazing women in medicine! They honored one of our doctors: “
@AbreoNina
stands out for her intellect, patient-centric care, advancements for breast cancer patients & being a female leader in medicine.”
@NYULangoneLI
🔗
It’s our pleasure to welcome gynecological oncologist Dr. Emeline Aviki (
@EmelineAvikiMD
) to our Perlmutter Cancer Center team!
Dr. Aviki will treat patients with
#gyncsm
cancers at our Mineola & Patchogue
@NYULangoneLI
locations.
Learn more:
We have many women who lead in cancer advances. JiYoung Ahn leads an
@theNCI
funded SPORE grant to better understand orodigestive tract health disparities to create personalized prevention & intervention.
#WomensHistoryMonth
@pophealthNYC
@nyugrossman
🔗
NYU Grossman School of Medicine has been ranked number 2 in the nation out of 192 schools as a best medical school for research, on
@usnews
2022–23 list of “Best Graduate Schools.” We are proud to be a partner with
@nyugrossman
@nyulangone
.
🔗
Our Dr. Paul Oberstein (
@md_oberstein
) is one of several pancreatic cancer doctors who see this as an exciting new treatment. But it will take some time to get this to work with a bigger number of patients.
@TopStoryNBC
@LlamasNBC
An experimental treatment appears to have been successful in halting the progression of one woman’s advanced pancreatic cancer.
Researchers think it has the potential to benefit millions more people.
Dr. Paul Oberstein joins
@LlamasNBC
to discuss the breakthrough treatment.
Patients can wait weeks for tumor pathology results to diagnose
#braincancer
. But now, new technology from neurosurgeon
@DanOrringerMD
demonstrates how AI can reduce that time to just three minutes.
Watch the
@NBCNewsNow
segment with
@DrAkshaySyal
🔽
On National Doctor’s Day, Perlmutter Cancer Center would like to say thanks to our physicians for the incredible work they do treating cancer patients!
#NationalDoctorsDay
Medical oncologist
@ElaineShumMD
has opened a phase 1/2 study of the highly selective EGFR inhibitor BLU-701 in patients with EGFR-Mutant non-small cell lung cancer.
#clinicaltrialsday2022
Learn more:
Proud to share our Program Director, Dr. Russell Berman
@bermar01
, has been appointed
@SocSurgOnc
Vice President. Congratulations on a well deserved new role, we are thrilled for you! 🎊
#SSO
#NYULangone
Congratulations to medical oncology fellows Dr. Peter Yu and Dr. Chengwei Peng, who received
@ASCO
Young Investigator Awards, providing funding to promising investigators to encourage and promote quality research in clinical oncology.
As the new director of breast cancer clinical research, medical oncologist Dr. Nancy Chan is helping us advance
#clinicaltrials
for
#breastcancer
patients. Learn more:
"Neoantigen strategies are the most promising vaccine strategies in oncology today," says Perlmutter Cancer Center deputy director Dr. Jeffrey Weber.
@AACR
Check out the discussion on the latest advancements in therapeutic cancer vaccines from
#AACR23
:
Our Amanda Lund (
@theLundLab
) is giving a major symposium talk at the upcoming
#AACR2023
: Tumor-associated lymphatic vessels and T cell transit through the tumor microenvironment. She’s
@CancerResearch
funded scientist
@AACR
Read more:
In a
@Medcape
series, a multidisciplinary team from
@nyulangone
discusses their collaborative efforts to optimize treatment in
#NSCLC
.
🎥 Check out episode 5 on adjuvant therapy, featuring our Drs.
@ElaineShumMD
,
@StermanDaniel
, and Abraham Chachoua:
Under the care of our Drs. Sylvia Adams and Richard Shapiro, fashion model
#LindaEvangelista
was treated at Perlmutter Cancer Center for breast cancer.
Linda—we admire your vulnerability and bravery in sharing your story in
@AppleTV
's
#TheSuperModels
:
Study looks at early-stage pancreatic cancer detection. Dr. Diane Simeone
@madamsurgeon
said exploring new technologies to detect cancers sooner in high-risk patients is critical to improving patient outcomes
@nyulangone
@nyugrossman
Well done to Perlmutter Cancer Center's Center for Blood Cancer Pilot Awardee: "The Role of Integrins in ALL" by Dr. Shella Saint Fleur-Lominy
@Dr_Shella_SFL
, Dr. Susan Schwab, and Dr. William Carroll!
#lylsm
#lylal
How can we reduce anxiety in patients undergoing
#radiationtherapy
? Our Dr. David Byun’s CurieUX, an immersive
#AI
patient education tool, is a promising step in right direction.
His team’s work
@NYULH_RadOnc
is featured on
@ASTRO_ORG
for
#NCRM23
here:
Congratulations to Dr. John Allendorf,
@Perlmutter_CC
leader &
@nyulisom
surgical oncology chief, who has been named the next chair of the department of surgery at
@NYULangoneLI
.
More on Dr. Allendorf:
Congrats to program manager Amin Yakubov, on being awarded the best programmatic or research staff research poster at the Annual
@NYULangoneHealth
Disparities Symposium for his poster, “Pre-Screening As a Tool for Increasing Oncology Trial Enrollment.”
Immunotherapies ‘offer incredible hope’ in journey toward
#multiplemyeloma
cure. “Some responses are lasting anywhere between 1 to 3 years, which is quite unusual in the relapsed and refractory setting,” our Dr.
@FaithEDavies1
notes
@healio
@nyugrossman
Medical oncologist Dr. Janice Mehnert
@JaniceM10
has opened a trial for patients with advanced malignancies. Learn more about this Phase I study evaluating the drug REGN3767 alone or in combination with REGN2810.
#clinicaltrials
The
@US_FDA
approved ciltacabtagene autoleucel (Carvykti) for people with multiple myeloma.
@FaithEDavies1
speaks to the
@theNCI
's Cancer Currents Blog on the importance of having another therapeutic approach in our toolbox.
🔗
Perlmutter Cancer Center is excited to welcome Dr. Michael Zelefsky, a a renowned leader in radiation oncology who will enhance our position as a leader in
#prostatecancer
with our
@NYULH_RadOnc
and
@NYUUrology
teams!
Learn about his expertise:
A study in
@Nature
led by
@Perlmutter_CC
researchers revealed that the amino acid valine plays a role in cancerous growth in T-cell acute lymphoblastic leukemia. Experiments showed that dietary valine deficiency can stall this cancer’s progression.
A study by
@nyulangone
researchers analyzed catheter-based therapies (CBTs) in cancer patients with intermediate/high-risk pulmonary embolism (PE).
In an interview with
@cardiacinterv
, study authors
@SripalBangalore
and
@LeivaOrly
discuss key findings ⤵️
On May 17, medical oncologist
@JSabari
will speak on the current standard of care for non-small lung cancer in the context of
#COVID19
, as well as the caregiver’s role in decision-making for a loved one with cancer.
@CancerCare
Register:
@Perlmutter_CC
congratulates Dr. Robert Banh, Assistant Professor of Biochemistry and Molecular Pharmacology at
@nyugrossman
for being a recipient of the
@DamonRunyon
award for breakthrough scientists.
Learn more:
A world-renowned expert in brachytherapy and treating genitourinary cancers, our Dr. Michael Zelefsky of
@NYULH_RadOnc
shares his vision in personalizing treatments, advancing radiation therapies, and expanding research in the field in a new Q&A:
How is the genomic landscape of multiple myeloma changing?
At the 2023
@COMyCongress
meeting, multiple myeloma specialist Dr. J. Gareth Morgan shares how the disease's mutational signatures has advanced research in the field with
@VJHemOnc
.
Watch here:
A $38.7 million
@NIH
grant will launch a new epidemiological study from
@FredHutch
on underrepresented Asian American, Native Hawaiian, and Pacific Islander health.
PIs will include our Dr. Jiyoung Ahn and Dr. Yu Chen
@PophealthNYC
! For more:
Pathologist Dr. Matija Snuderl speaks with
@Inside_PM
on the role of DNA Methylation in
#Neuropathology
and new technologies in
#epigenetics
being adopted at to drive this field forward.
Listen here:
Congratulations to our
@NYUGSOM_HemeOnc
fellow Dr.. Minas Economides
@minaseconomides
for getting an ASCO YIA to support his research and an ASCO merit award for his high scoring abstract.
#ASCO23
Our
@NYUGSOM_Path
investigators have identified a trimolecular complex that may yield new strategies to improve checkpoint inhibitor efficacy in AML & other solid cancers.
Learn more with co-authors
@Iannisaifantis
,
@jwang133
,
@Xufeng_Chen
& Dr. Qiao Lu:
Our Dr. Jeffrey Weber spoke with the
@WSJ
about the promising melanoma research he presented at
#AACR23
today. An
#mRNA
shot & pembro helped prevent relapse in hi-risk patients
@moderna_tx
@Merck
We have many women who lead in cancer advances.
@drosmannyu
is a melanoma researcher who has been central to an
@NCI
-funded grant to develop tools to predict melanoma immunotherapy treatment outcomes.
@NYUGSOMimcg
#WomensHistoryMonth
🔗
With a focus on discovering new and effective immunotherapies for esophageal cancer, a new Stand Up to Cancer (
@SUC2
) project will be co-led by our Dr. Kwok-Kin Wong and Dr. Anil K. Rustgi of
@columbiacancer
.
Learn more:
On 9/23,
@nyugrossman
is offering an accredited course on the pathophysiology, diagnosis, & treatment of pancreatic diseases including pancreatitis, high-risk & pre-cancerous conditions, & pancreatic cancer.
Register to hear our cancer/surgery experts:
We're excited to announce new leadership for our Clinical Trials Office: medical director
@BPothuri
& Phase 1 director
@kspencer725
. Additionally, we've joined a national clinical trials network, expanding access to early stage clinical trials.
🔗
Medical oncologist Dr. Jeffrey Weber opened a trial to evaluate the efficacy & safety of a new drug combination compared with nivolumab after complete resection of
#melanoma
in patients at high risk of recurrence. Learn more:
This is how you make raising money for cancer research fun! Staff at
@nyulangone
's Perlmutter Cancer Center-Long Island held a “Making Strides Against Breast Cancer Boot Camp” & asked people to donate. Thanks to team captain
@amandamarie7161
for organizing!
@AmericanCancer
.
“We’re proud to partner with the
@AmericanCancer
to raise awareness about breast cancer,” says Dr. Sylvia Adams, director of our breast cancer center, pictured here with fellow PCC breast cancer researcher, Dr. Theresa Vincent.
Medical oncologist Dr. Jeffrey Weber opened a trial for patients with unresectable stage III or stage IV
#melanoma
. This study tests the safety, tolerability, & effectiveness of the drug tocilizumab when given with the drugs ipilimumab & nivolumab.
Daughters of a breast cancer survivor, Maya and Chandni raised money to make homemade care packages for our patients at Perlmutter Cancer Center—Mineola.
Thank you for inspiring positivity, joy, and hope in many—both inside and outside the infusion center 💜
Join
@Perlmutter_CC
’s Dr. Deanna Gerber on
@NYUDocs
this Wednesday March 15 (8-9 a.m. ET) to discuss critical advances in gynecological cancers, including ovarian, cervical & endometrial.
@SiriusXM
(Ch. 110). All part of
#Women
'sHealthMonth
@nyulangone
Drug shortages are not new — but how are recent chemotherapy drug shortages affecting clinicians and patients?
In an interview with
@TargetedOnc
, Dr. Joshua Sabari (
@JSabari
) discusses what oncologists are doing to help address this problem:
In response to the annual
@AACR
report, cancer experts, like
@VamsiVelcheti
, draw attention to how record drug shortages continue to affect clinicians, researchers and—most importantly—patients.
▶️ Read more on
@CNN
:
Our Tory Foster and Anita McFarlane at the
@BK_Marathon
raising funds for Stamp Out Cancer Brooklyn, an initiative that aims to reduce the overall burden of cancer and alleviate cancer-related disparities in Brooklyn.
@pophealthNYC
.
Learn more:
.
@NCICRCHD
-hosted programs enable Dr. Jiyoung Ahn of
@pophealthNYC
to evaluate the complex factors perpetuating disparities in cancer incidence and mortality rates among racial, ethnic, and underserved populations.
Watch to hear more about Dr. Ahn's work ⤵️
Congratulations to Dr. Joseph Ravenell, who is among
@cancerhealthmag
's 25 recipients of remarkable individuals who are helping people affected by cancer live their best lives.
@pophealthNYC
Our medical oncologist
@VamsiVelcheti
uses cancer biomarkers to care for people with non-small cell lung cancer. Read more about Dr. Velcheti's work and how biomarkers make a dramatic difference in those with late-stage disease.
🔗
Perlmutter Cancer Center is among four NYC cancer centers to receive a $1 million grant from Stamp Out To Cancer (
@SU2C
) to improve lung cancer care for underserved minorities by providing technology-enabled monitoring of immunotherapy side effects.
🔗
Our very own PD, Dr. Russell Berman, MD
@bermar01
, professor and vice chair for education & faculty affairs within the Dept of Surgery, was the recipient of the 2021 GME Program Director of the Year Award from the Educator Community at NYU Grossman School of Medicine
@nyugrossman